Department of Cardiology, Stockholm South General Hospital, Stockholm, Sweden
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Heart. 2021 Jul;107(14):1167-1172. doi: 10.1136/heartjnl-2020-318733. Epub 2021 Feb 23.
The objective of this cohort study was to analyse long-term relative survival in patients with bicuspid aortic valve (BAV) who underwent aortic valve surgery.
We studied 865 patients with BAVs who participated in three prospective cohort studies of elective, open-heart, aortic valve surgery at the Karolinska University Hospital, Stockholm, Sweden, between 2007 and 2020. The expected survival for the age, sex and calendar year-matched general Swedish population was obtained from the Human Mortality Database. The Ederer II method was used to calculate relative survival, which was used as an estimate of cause-specific survival.
No differences were found in the observed versus expected survival at 1, 5, 10 or 12 years: 99%, 94%, 83% and 76% vs 99%, 93%, 84% and 80%, respectively. The relative survival at 1, 5, 10 and 12 years was 100% (95% CI 99% to 100%), 101% (95% CI 99% to 103%), 99% (95% CI 95% to 103%) and 95% (95% CI 87% to 102%), respectively. The relative survival at the end of follow-up tended to be lower for women than men (86% vs 95%). The mean follow-up was 6.3 years (maximum 13.3 years).
The survival of patients with BAV following aortic valve surgery was excellent and similar to that of the general population. Our results suggest that the timing of surgery according to current guidelines is correct and provide robust long-term survival rates, as well as important information about the natural history of BAV in patients following aortic valve surgery.
本队列研究旨在分析行主动脉瓣手术的二叶式主动脉瓣(BAV)患者的长期相对生存率。
我们研究了 865 例在瑞典斯德哥尔摩卡罗林斯卡大学医院接受择期、开胸、主动脉瓣手术的 BAV 患者,这些患者参加了三项前瞻性队列研究,研究时间为 2007 年至 2020 年。从人类死亡率数据库获得与年龄、性别和日历年份相匹配的一般瑞典人群的预期生存率。采用 Ederer II 法计算相对生存率,作为特定病因生存率的估计值。
在 1、5、10 和 12 年时,观察生存率与预期生存率无差异:99%、94%、83%和 76%与 99%、93%、84%和 80%。1、5、10 和 12 年的相对生存率分别为 100%(95%CI 99%100%)、101%(95%CI 99%103%)、99%(95%CI 95%103%)和 95%(95%CI 87%102%)。随访结束时,女性的相对生存率低于男性(86%比 95%)。平均随访时间为 6.3 年(最长 13.3 年)。
BAV 患者行主动脉瓣手术后的生存率极佳,与一般人群相似。我们的结果表明,根据现行指南选择手术时机是正确的,为患者提供了长期生存率的可靠数据,并为主动脉瓣手术后 BAV 的自然史提供了重要信息。